A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients - Concepedia

Concepedia

Publication | Closed Access

A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients

126

Citations

47

References

2014

Year

Anet Valdés-Zayas, Eduardo R. Santiesteban, Yoanna I. Flores, Fernando Areces, Maurenis Hernández, Carmen Viada, Ivis C. Mendoza, Pedro P. Guerra, Elena García, Ramón A. Ortiz,

Clinical Cancer Research

Abstract

Switch maintenance with racotumomab-alum is an effective and a well-tolerated treatment option for patients with advanced NSCLC.

References

	Year	Citations

Page 1